Published in N Engl J Med on April 17, 1975
Toxic epidermal necrolysis in Stevens--Johnson syndrome. Can Med Assoc J (1978) 0.83
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med (1995) 5.18
Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol (1994) 4.07
Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med (1985) 3.37
Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06
Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84
Passive transfer by cells of type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.81
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med (1978) 2.50
Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum (1988) 2.41
Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum (1982) 2.35
Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29
Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries. Natl Med Care Util Expend Surv B (1987) 2.23
Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16
Collagen autoimmune arthritis. Annu Rev Immunol (1984) 2.10
Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann Intern Med (1993) 2.04
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum (1998) 1.93
Evaluation of the national swing-bed program in rural hospitals. Health Care Financ Rev (1988) 1.81
Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71
Altered lymphocyte reactivity in rheumatoid arthritis. Arthritis Rheum (1976) 1.58
Synovial fluid tests. What should be ordered? JAMA (1990) 1.55
Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med (1991) 1.55
Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52
The occurrence of cryoproteins in synovial fluid; the association of a complement-fixing activity in rheumatoid synovial fluid with cold-precipitable protein. J Clin Invest (1971) 1.51
Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. Arthritis Rheum (1983) 1.51
Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49
Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum (1983) 1.48
Morphologic demonstration of two stages in the development of type II collagen-induced arthritis. Lab Invest (1982) 1.47
Autoimmunity to collagen in adjuvant arthritis of rats. J Clin Invest (1980) 1.44
Home health agency benefits. Health Care Financ Rev Annu Suppl (1992) 1.43
Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol (1980) 1.43
Topics in clinical medicine. Complement levels in disease. Johns Hopkins Med J (1967) 1.29
Antigen-specific suppression of type II collagen-induced arthritis by collagen-coupled spleen cells. J Immunol (1982) 1.25
Pathogenesis of rheumatoid arthritis. Lancet (1993) 1.25
Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta. Clin Exp Immunol (1992) 1.22
Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases. Am J Med (1980) 1.21
Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N Engl J Med (1981) 1.17
Preliminary criteria for the classification of systemic lupus erythematosus (SLE). Evaluation in early diagnosed SLE and rheumatoid arthritis. Arthritis Rheum (1974) 1.16
Type II collagen autoimmunity in otosclerosis and Meniere's Disease. Science (1982) 1.16
Dietary fish oil augments the induction of arthritis in rats immunized with type II collagen. J Immunol (1984) 1.14
Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis. Arthritis Rheum (1987) 1.14
Gold does not alter the arthritic, humoral, or cellular responses in rats with type II collagen-induced arthritis. Arthritis Rheum (1980) 1.12
Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. J Exp Med (1981) 1.12
Antigen-specific suppression of collagen arthritis by adoptive transfer of spleen cells. Clin Immunol Immunopathol (1984) 1.10
Impaired cell-mediated immunity in systemic lupus erythematosus (SLE). A controlled study of 23 untreated patients. Am J Med (1975) 1.09
Augmentation of collagen arthritis by synthetic analogues of retinoic acid. J Immunol (1982) 1.08
Effect of psychological stress on the induction of arthritis in rats. Arthritis Rheum (1980) 1.08
Attenuation of an adjuvant arthritis by type II collagen. J Immunol (1983) 1.06
Systemic lupus erythematosus with a protein-losing enteropathy. JAMA (1976) 1.05
Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid arthritis. Arthritis Rheum (1981) 1.05
Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol (1983) 1.04
Controlled trial of cyclophosphamide in rheumatoid arthritis. Arthritis Rheum (1976) 1.04
Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases. Clin Immunol Immunopathol (1976) 0.98
Type II collagen-induced autoimmune otospongiosis. A preliminary report. Ann Otol Rhinol Laryngol (1983) 0.97
Effect of cyclophosphamide, hydrocortisone and levamisole on collagen-induced arthritis in rats. Arthritis Rheum (1981) 0.97
A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum (1996) 0.97
Polyneuropathy and anasarca: evidence for a new connective-tissue syndrome and vasculopathic contribution. Ann Intern Med (1976) 0.97
POEMS syndrome with myocardial infarction: observations concerning pathogenesis and review of the literature. Semin Arthritis Rheum (1992) 0.96
Cyclosporin A treatment of refractory rheumatoid arthritis. Arthritis Rheum (1987) 0.95
The role of collagen autoimmunity in animal models and human diseases. J Invest Dermatol (1982) 0.95
Drug-induced lupus: an adjuvant disease? Am J Med (1981) 0.94
Total lymphoid irradiation therapy in refractory rheumatoid arthritis. Fifteen- to forty-month followup. Arthritis Rheum (1984) 0.94
A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. J Rheumatol (1997) 0.94
Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum (1986) 0.93
Arthritis in viral hepatitis. Report of two cases and review of the literature. Johns Hopkins Med J (1973) 0.92
Type II collagen-induced auricular chondritis. Arthritis Rheum (1982) 0.92
Experimental synovitis induced by collagen-specific T cell lines. Cell Immunol (1989) 0.91
Arthritis with an inflammatory dermatosis resembling Sweet's syndrome. Report of a unique case and review of the literature on arthritis associated with the inflammatory dermatoses. Am J Med (1976) 0.91
Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. J Rheumatol (1997) 0.90
HLA-DR4 is not a requisite for autoimmunity to collagen in rheumatoid arthritis. Arthritis Rheum (1984) 0.90
Carpo:metacarpal ratio. A new quantitative measure of radiologic progression of wrist involvement in rheumatioid arthritis. Arthritis Rheum (1976) 0.90
Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis. Cell Immunol (1984) 0.89
Modulation of human lymphocyte function by C3a and C3a(70-77). J Exp Med (1982) 0.89
Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis. Clin Exp Immunol (1993) 0.89
Complement in synovial fluid. Johns Hopkins Med J (1970) 0.89
Complement-fixing activity of rheumatoid synovial fluid. Ann Rheum Dis (1972) 0.88
An arthritogenic lymphokine in the rat. J Exp Med (1985) 0.88
Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig. J Immunol (1976) 0.88
Interleukin-2 diphtheria fusion protein (DAB486IL-2) in refractory rheumatoid arthritis. A double-blind, placebo-controlled trial with open-label extension. Arthritis Rheum (1995) 0.88
Excess disabilities of mentally impaired aged: impact of individualized treatment. Gerontologist (1971) 0.87
Activation of rat synovium by iron. Arthritis Rheum (1988) 0.86
Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss. Lancet (1991) 0.86
Intractable vasculitis, resorptive osteolysis, and immunity to type I collagen in type VIII Ehlers-Danlos syndrome. Arthritis Rheum (1991) 0.86
Exacerbation of collagen arthritis by noise stress. J Rheumatol (1983) 0.86
Connective tissue disease can develop in rats either spontaneously or after total lymphoid irradiation. J Rheumatol (1984) 0.85
HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum (1996) 0.85
Intraarticular injection of arthritogenic factor causes mast cell degranulation, inflammation, fat necrosis, and synovial hyperplasia. Lab Invest (1988) 0.85
The effect of minocycline in rat models of inflammatory arthritis: correlation of arthritis suppression with enhanced T cell calcium flux. Cell Immunol (1996) 0.85
Partial dissociation of rheumatoid synovial fluid cryoprotein: micro-complement fixation by IgG- or IgG and IgM-containing fractions and denatured calf thymus DNA. J Immunol (1971) 0.84
Type II collagen-induced arthritis. Ann N Y Acad Sci (1985) 0.84
Adjuvant-induced arthritis in rats. Evidence that autoimmunity to homologous collagens types I, II, IX and XI is not involved in the pathogenesis of arthritis. Clin Exp Immunol (1990) 0.84
Progress in the understanding of inducible models of chronic arthritis. Rheum Dis Clin North Am (1987) 0.84
Collagens stimulate the production of mononuclear cell factor (MCF) and prostaglandins (PGE2) by human monocytes. Trans Assoc Am Physicians (1980) 0.84
Collagen arthritis in the rat is initiated by CD4+ T cells and can be amplified by iron. Cell Immunol (1989) 0.84
Low dose penicillin for gonococcal arthritis. A comparative therapy trial. JAMA (1976) 0.83